GSK3B and cancer: Collectively, our findings supports the hypothesis that activation of the ATM/AKT/GSK-3β signaling pathway leading to CDK4/CDK6/cyclin D1 overexpression plays a key role in LDR-induced hormesis, and is responsible for the difference of hormesis induced by LDR in normal and cancer cells.